Overview of fat-soluble vitamin deficiencies

The fat-soluble vitamins (A, D, E and K) require bile for absorption from the gastrointestinal tract, and travel through the lymphatic system before entering circulation. Fat-soluble vitamins are not easily excreted, and the risk of toxicity is greater than with water-soluble vitamins. Excesses are stored primarily in the liver and adipose tissues, so deficiencies may not be seen until weeks or months of inadequate intake. People with conditions causing fat malabsorption (eg cystic fibrosis, pancreatic insufficiency, short bowel syndrome, bariatric surgery) are at higher risk of fat-soluble vitamin deficiencies.

See Clinical aspects of fat-soluble vitamins for the physiological function of fat-soluble vitamins, and the effects and risk factors for deficiency.

Dietary sources of fat-soluble vitamins are listed in Dietary sources of key vitamins, minerals and trace elements.

The evidence for the optimal dosage of fat-soluble vitamins and outcomes is limited; dosages given in this topic are a guide only.

Note: The evidence for the optimal dosage of fat-soluble vitamins and outcomes is limited; dosages given in this topic are a guide only.

People deficient in multiple fat-soluble vitamins or with a condition causing fat malabsorption can be treated with a water-miscible, high-potency fat-soluble multivitamin formulation such as VitABDECK (contains vitamin A 2500 international units [IU], vitamin D 440 IU, vitamin E 150 IU, and vitamin K 150 micrograms). People deficient in a specific fat-soluble vitamin may only need treatment with a high-dose supplement of that vitamin.

Baseline testing of fat-soluble vitamin blood concentration should only be carried out in people at risk of deficiency. Repeat testing may be used to determine if the patient is having an adequate response to therapy and to ensure that the patient is not receiving an excessive dosage; however, evidence to guide timing of repeat testing is lacking. Disease-specific guidelines may provide recommendations for the frequency of repeat testing. In general, the requirement for and frequency of repeat testing should be individualised based on which micronutrient is supplemented and the severity of the deficiency. For information about the requirement for and frequency of vitamin D testing, see Vitamin D treatment regimens.

Supplementation of fat-soluble vitamins should not continue indefinitely. To avoid toxicity, recheck blood concentration after 3 months, if appropriate, and stop supplementation if the deficiency has resolved. Long-term supplementation may be required in patients with a chronic condition causing fat malabsorption.

Table 1. Clinical aspects of fat-soluble vitamins

vitamin A

vitamin D

vitamin E

vitamin K

vitamin A

physiological function

protein synthesis and cell differentiation

maintains vision

maintains health of epithelial tissues and skin

supports reproduction and growth

effects of deficiency

impaired night vision

xerophthalmia (conjunctival and corneal dryness)

loss of integrity of skin and mucous membranes resulting in poor absorption of nutrients

decreased immune function

plugging of hair follicles

painful joints related to cessation of bone growth

risk factors for deficiency

liver disease

cystic fibrosis and other fat malabsorption syndromes

anorexia nervosa

very low-fat diets (particularly if vegetarian or vegan)

chronic infection

vitamin D

physiological function

bone health—maintains calcium and phosphate homeostasis (enhances their absorption from gastrointestinal tract, reabsorption from kidneys, and mobilisation from bone into blood)

effects of deficiency

osteomalacia (adults)

rickets (children)

impaired modulation of immune and neuromuscular systems

risk factors for deficiency

dark skin, no sun exposure

elderly with limited sun exposure

inadequate calcium intake

liver disease, untreated coeliac disease, kidney disease and other malabsorption conditions

corticosteroid use

vitamin E

physiological function

antioxidant in cell membranes; protects against fatty acid peroxidation

effects of deficiency

haemolytic anaemia

central or peripheral neuropathy, myopathy

increased atherosclerosis

risk factors for deficiency

cystic fibrosis and other fat malabsorption syndromes

premature infants

vitamin K

physiological function

blood coagulation; activates several clotting factors, including prothrombin

bone calcification

effects of deficiency

bleeding disorders

may cause decreased bone density

risk factors for deficiency

cystic fibrosis and other fat malabsorption syndromes

prolonged use of antibiotics